Literature DB >> 11044124

Separable mechanisms of attachment and cell uptake during retrovirus infection.

S Sharma1, A Miyanohara, T Friedmann.   

Abstract

In the absence of viral envelope gene expression, cells expressing human immunodeficiency virus type 1 (HIV-1) gag and pol, accessory HIV functions, and a vector genome RNA produce and secrete large amount of noninfectious virus-like particles (VLPs) into the conditioned medium. After partial purification, such HIV-1 VLPs can be made infectious in cell-free conditions in vitro by complex formation with lipofection reagents or with the G protein of vesicular stomatitis virus (VSV-G). The resulting in vitro-modified HIV-1 particles are able to infect nondividing cells. Infectivity of envelope-free HIV VLPs can also be induced by prior modification of target cells through exposure to partially purified VSV-G vesicles. Similarly, infection can be carried out by attachment of envelope-free noninfectious VLPs to unmodified cells followed by subsequent treatment of cells with VSV-G. We interpret these findings to indicate that interaction between a viral envelope and a cell surface receptor is not necessary for the initial virus binding to the cells but is required for subsequent cell entry and infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044124      PMCID: PMC110954          DOI: 10.1128/jvi.74.22.10790-10795.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.

Authors:  N Srinivasakumar; N Chazal; C Helga-Maria; S Prasad; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments.

Authors:  D Lavillette; A Ruggieri; S J Russell; F L Cosset
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector.

Authors:  T Shimada; H Fujii; H Mitsuya; A W Nienhuis
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

4.  Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein.

Authors:  A Abe; A Miyanohara; T Friedmann
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 5.  HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology.

Authors:  M Emerman; M H Malim
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

6.  Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents.

Authors:  S Sharma; F Murai; A Miyanohara; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

7.  Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein.

Authors:  F L Hall; E M Gordon; L Wu; N L Zhu; M J Skotzko; V A Starnes; W F Anderson
Journal:  Hum Gene Ther       Date:  1997-12-10       Impact factor: 5.695

8.  In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.

Authors:  A Abe; S T Chen; A Miyanohara; T Friedmann
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  A third-generation lentivirus vector with a conditional packaging system.

Authors:  T Dull; R Zufferey; M Kelly; R J Mandel; M Nguyen; D Trono; L Naldini
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction.

Authors:  M Pizzato; S A Marlow; E D Blair; Y Takeuchi
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

View more
  12 in total

1.  Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycations.

Authors:  Warren Denning; Suvendu Das; Siqi Guo; Jun Xu; John C Kappes; Zdenek Hel
Journal:  Mol Biotechnol       Date:  2013-03       Impact factor: 2.695

2.  Entry kinetics and cell-cell transmission of surface-bound retroviral vector particles.

Authors:  Lee S O'Neill; Amy M Skinner; Josha A Woodward; Peter Kurre
Journal:  J Gene Med       Date:  2010-05       Impact factor: 4.565

3.  Synchronized infection of cell cultures by magnetically controlled virus.

Authors:  Hillel Haim; Israel Steiner; Amos Panet
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo.

Authors:  Yung-Wei Pan; Jarrad M Scarlett; Tammy T Luoh; Peter Kurre
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells.

Authors:  John R Mascola; Mark K Louder; Christine Winter; Ranjani Prabhakara; Stephen C De Rosa; Daniel C Douek; Brenna J Hill; Dana Gabuzda; Mario Roederer
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.

Authors:  Renaud Burrer; Sandrine Haessig-Einius; Anne-Marie Aubertin; Christiane Moog
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.

Authors:  Dimitri Lavillette; Alessia Ruggieri; Bertrand Boson; Marielle Maurice; François-Loïc Cosset
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles.

Authors:  D Marsac; D Loirat; C Petit; O Schwartz; M-L Michel
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 9.  Early steps of retrovirus replicative cycle.

Authors:  Sébastien Nisole; Ali Saïb
Journal:  Retrovirology       Date:  2004-05-14       Impact factor: 4.602

10.  Cell-cell transmission of VSV-G pseudotyped lentivector particles.

Authors:  Amy M Skinner; Santhosh Chakkaramakkil Verghese; Peter Kurre
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.